(Q28218700)

2

0 references

Yumei Ye

3

0 references

Juan D Martinez

4

0 references

Ming-He Huang

5

0 references

Charles Y Lui

6

0 references

Jose R Perez-Polo

7

0 references

Barry F Uretsky

American Journal of Physiology Heart and Circulatory Physiology

8

0 references

language of work or name

English

0 references

publication date

June 2007

0 references

published in

0 references

volume

292

0 references

issue

6

0 references

page(s)

H2891-7

0 references

cites work

Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01269.2006

Reduction of infarct size by short-term pretreatment with atorvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01269.2006

Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01269.2006

Preconditioning versus postconditioning: mechanisms and therapeutic potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01269.2006

Pharmacology of platelet inhibition in humans: implications of the salicylate-aspirin interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01269.2006

Effect of statin treatment on coronary collateral development in patients with diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01269.2006

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01269.2006

Acute aspirin treatment abolishes, whereas acute ibuprofen treatment enhances morphine-induced cardioprotection: role of 12-lipoxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01269.2006

Aspirin, but not clopidogrel, reduces collateral conductance in a rabbit model of femoral artery occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01269.2006

Ramatroban, a thromboxane A2 receptor antagonist, prevents macrophage accumulation and neointimal formation after balloon arterial injury in cholesterol-fed rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01269.2006

Effect of acetylsalicylic acid on nuclear factor-kappaB activation and on late preconditioning against infarction in the myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01269.2006

Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01269.2006

Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01269.2006

Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01269.2006

Intravenous aspirin at reperfusion does not reduce infarct size in the dog with a residual critical stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01269.2006

Low-dose aspirin for the prevention of atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01269.2006

Selectivity of cyclo-oxygenase inhibitors in human pulmonary epithelial and smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01269.2006

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01269.2006

Statins augment collateral growth in response to ischemia but they do not promote cancer and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01269.2006

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01269.2006

Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01269.2006

Effect of aspirin on late preconditioning against myocardial stunning in conscious rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01269.2006

Aspirin in peripheral arterial disease: breakthrough or pitfall?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01269.2006

Determination of expression of cyclooxygenase-1 and -2 isozymes in canine tissues and their differential sensitivity to nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01269.2006

Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01269.2006

Postconditioning: reduction of reperfusion-induced injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01269.2006

Differential Suppression of Thromboxane Biosynthesis by Indobufen and Aspirin in Patients With Unstable Angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01269.2006